Deutsche Tageszeitung - Animal testing put to the test in Swiss vote

Advertisement Image
Advertisement Image
Advertisement Image
Advertisement Image
Advertisement Image

Animal testing put to the test in Swiss vote


Animal testing put to the test in Swiss vote
Animal testing put to the test in Swiss vote

Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.

Advertisement Image

Change text size:

Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.

But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.

Researchers insist that medical progress is impossible without experimentation.

At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.

These structures, made up of cells, make it possible to test a large number of potential treatments.

"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.

But even she said it would be impossible to do all the research without animal experimentation and clinical trials.

This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.

- Strict protocols -

Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.

The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.

The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.

The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.

"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.

In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.

The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.

Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.

- Proposal 'goes too far' -

Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.

The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.

"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.

All the major political parties in Switzerland are against the proposal.

For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.

Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".

Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.

But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.

For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".

However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."

(L.Møller--DTZ)

Featured

With EuroPride, Lisbon courts LGBTQ travellers

Rainbow flags will fill Lisbon's streets on Saturday when the Portuguese capital hosts the annual EuroPride parade in support of LGBTQ rights which organisers hope will cement its standing as a gay-friendly destination.

Karbon-X and Directions Group Join Forces to Develop a Residential Solar Carbon Project Aligned with Alberta's TIER Program

CALGARY, AB / ACCESS Newswire / June 17, 2025 / Karbon-X Corp. (OTCQX:KARX), a vertically integrated climate solutions company, has entered into a strategic agreement with Directions Group Inc., a Canadian leader in clean energy sales and growth strategy. The partnership will focus on the development and implementation of a residential solar carbon project designed to generate offset credits eligible under Alberta's Technology Innovation and Emissions Reduction (TIER) regulation, one of Canada's most robust compliance carbon pricing systems.

Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru

VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1). Los Chapitos is Camino's second copper project with partner Nittetsu Mining Co, Ltd. ("Nittetsu"), which can earn a 35% interest in Los Chapitos once it completes a total investment of CDN$10 Million (see news release dated June 14, 2023). Rio Tinto, a major copper producer, recently staked claims adjacent to Los Chapitos (see news release dated May 17, 2024). Camino is also advancing its mine development project, the Puquios Copper Project, with Nittetsu Mining in Chile (see news release dated April 17, 2025).

Corsair Signs Strategic Partnership with Kera Energy for Global Distribution of Pyrolysis Oil

New partnership expands global access to Corsair's recycled plastic oil across Europe, Asia, and the Americas.

Change text size:

Advertisement Image